A pharmacovigilance officer can use an AI research assistant on a schedule to monitor drug safety signals automatically, freeing up hours of manual database searching each week.
Meet Priya
Priya works in drug safety at a mid-sized pharmaceutical company. Her job is to watch for emerging safety signals, which means patterns of side effects or adverse events (bad reactions) that show up in patients taking a drug.
She does not just track one drug. She tracks a whole portfolio. Some are already on the market. Others are still in late-stage trials.
Every week, she used to spend two to three hours reading through FDA MedWatch updates, EMA safety communications, PubMed alerts, and industry news sites. If she missed something, it could mean a delayed safety report or, worse, a missed signal that harms patients.
That kind of manual searching is exhausting. And it is easy to miss things when you are bouncing between five different websites.
The Problem With Manual Monitoring
Drug safety moves fast. A new case series can appear in a medical journal on a Tuesday. The FDA can issue a safety communication on a Thursday. A regulator in Europe might update a product label on Friday.
None of these sources talk to each other. So you have to check them all, separately, all the time.
For Priya, the biggest risk was not knowing what she did not know.
How She Set Up AIDular
Priya signed up at aidular.com and set up a weekly report using plain English. No coding, no spreadsheets.
Here is roughly what she typed as her tracking prompt:
"Every week, search for new drug safety signals, adverse event reports, FDA MedWatch updates, EMA pharmacovigilance news, and any published case reports or meta-analyses linking serious side effects to drugs in the GLP-1 agonist class. Include any regulatory label changes or new warnings. Send me a sourced summary."
AIDular searches the web on her chosen schedule and emails her a clean, sourced report every Monday morning. Each item has a headline, a short summary, and a link to the original source.
She can read the whole thing in 15 minutes over her first coffee.
What She Gets in Her Inbox
A typical weekly report might include:
- A new FDA safety communication about a GLP-1 drug and a rare thyroid finding
- A published case series in a peer-reviewed journal linking a drug to a previously unreported adverse event
- An EMA update on a label change for a competing product in the same class
- A conference abstract flagging a new signal picked up in post-market surveillance data
Each of these would have taken her a separate search to find manually. Now they come to her in one place.
Why This Matters
Missing a safety signal is not just a compliance problem. It can affect real patients. Priya's job is to make sure signals get caught early, reported correctly, and escalated when needed.
Having a weekly digest does not replace her judgment. She still reads the sources and decides what to do next. But it means she walks into every Monday with a clear picture of what happened in her space the week before.
She also uses a second AIDular report, set to monthly, to track broader trends in pharmacovigilance regulation across the US, EU, and UK. That one feeds into her team's quarterly compliance review.
Try It Yourself
If you work in drug safety, medical affairs, or clinical research, and you spend too much time chasing updates across multiple sources, this kind of scheduled report can genuinely help.
You can start free at aidular.com. Write your tracking prompt in plain English, pick your schedule, and let AIDular do the searching. Your inbox will thank you.